| Recruiting | Study of DONQ52 in Active Celiac Disease Celiac Disease | Phase 2 | 2025-12-16 |
| Recruiting | A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER Extensive Stage Small Cell Lung Cancer | Phase 1 | 2025-10-08 |
| Recruiting | Study of AUBE00 in Patients With Solid Tumors Solid Tumors | Phase 1 | 2025-06-05 |
| Enrolling By Invitation | Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial) Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), Behçet's Syndrome (BS) | Phase 1 | 2024-12-09 |
| Recruiting | Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), Behçet's Syndrome (BS) | Phase 1 | 2024-08-19 |
| Recruiting | A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors Solid Tumor | Phase 1 | 2023-05-24 |
| Completed | A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors Solid Tumor | Phase 1 | 2023-04-17 |
| Completed | A Decentralized Home-Based Study To Investigate Novel Objective Biomarker Of Gluten-Mediated Symptoms In Celia Celiac Disease | — | 2023-03-08 |
| Completed | Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients Celiac Disease | Phase 1 | 2022-09-19 |
| Unknown | Post-Marketing Drug Intensive Monitoring Surveillance of EDIROL in Patients With Postmenopausal Osteoporosis Postmenopausal Osteoporosis | — | 2022-08-01 |
| Terminated | A Dose-escalation Study of LUNA18 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion Locally Advanced or Metastatic Solid Tumors | Phase 1 | 2021-10-08 |
| Completed | An Observational Study of Patients With Endometriosis to Evaluate the Usefulness of the MEDL Score, a New Meth Endometriosis | — | 2021-07-28 |
| Active Not Recruiting | A Phase I Study of ERY974 in Patients With Hepatocellular Carcinoma Hepatocellular Carcinoma (HCC) | Phase 1 | 2021-06-01 |
| Completed | The Biomarker Exploratory Study in Prospective Multicenter Observational Study of Atezolizumab Combination The Non-small Cell Lung Cancer, Extensive Disease Small Cell Lung Cancer | — | 2021-04-07 |
| Completed | A Clinical Pharmacology Study to Evaluate the Effect of GYM329 on Disuse Muscle Atrophy in Healthy Volunteer Healthy Volunteers | Phase 1 | 2021-02-10 |
| Completed | Excretion Balance, PK and Metabolism of a Single Oral Dose of [14C]PCO371 Healthy Volunteers | Phase 1 | 2020-11-25 |
| Active Not Recruiting | A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion Locally Advanced or Metastatic Solid Tumors | Phase 1 | 2020-09-10 |
| Completed | Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2) Non-small Cell Lung Cancer, Extensive Disease Small Cell Lung Cancer | — | 2020-08-21 |
| Terminated | A Clinical Study Investigating the Safety, Tolerability, PK and PD of PCO371 in Patients With Hypoparathyroidi Hypoparathyroidism | Phase 1 | 2020-07-23 |
| Unknown | CAPOXIRI+Bevacizumab vs. FOLFOXIRI+Bevacizumab for mCRC Metastatic Colorectal Cancer | Phase 2 | 2019-10-11 |
| Completed | PD-L1 Expression in Japanese Renal Cell Carcinoma Patients Renal Cell Carcinoma | — | 2018-12-16 |
| Completed | A Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic NSCLC (J-TAIL) Non-small-Cell Lung Cancer | — | 2018-08-15 |
| Completed | A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia o Hyperphosphatemia | Phase 1 | 2016-12-01 |
| Completed | A Study of ERY974 in Patient With Advanced Solid Tumors Solid Tumors | Phase 1 | 2016-08-01 |
| Completed | Non-drug Study to Assess the Suitability of Assessment Scales in Japanese Individuals With Down Syndrome Aged Down Syndrome | — | 2015-06-01 |
| Terminated | A Single Ascending Dose Study of PCO371 in Healthy Volunteers Healthy | Phase 1 | 2015-06-01 |
| Completed | A Phase 2 Study of CIM331 for Atopic Dermatitis Patients Atopic Dermatitis | Phase 2 | 2013-11-01 |
| Completed | A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease Patients Alzheimer's Disease | Phase 1 | 2012-06-01 |
| Completed | Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma) Hepatocellular Carcinoma | Phase 1 | 2009-09-01 |
| Terminated | A Study to Evaluate the Efficacy, Safety and Pharmacokinetics/Pharmacodynamics (PK/PD) of Ocrelizumab in Patie Rheumatoid Arthritis | Phase 2 | 2008-10-01 |
| Completed | A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma) Advanced or Metastatic HCC | Phase 1 | 2008-09-01 |
| Completed | Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients Anemia | Phase 3 | 2008-05-01 |
| Completed | A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Deve Rheumatoid Arthritis | — | 2008-04-01 |
| Completed | Clinical Study of R744 to Hemodialysis Patients Hemodialysis Patients | Phase 3 | 2007-06-01 |
| Completed | Clinical Study of R744 to Predialysis Patients( Phase III, Comparative Study in Comparison With Epoetin Beta) Predialysis Patients | Phase 3 | 2007-06-01 |
| Completed | Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metast Metastatic Breast Cancer | Phase 2 | 2007-04-01 |
| Completed | Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary Osteoporosis Primary Osteoporosis | Phase 3 | 2007-03-01 |
| Completed | Clinical Study of R744 to Predialysis Patients Anemia in Pre-Dialysis Patients | Phase 3 | 2007-02-01 |
| Completed | Correction Study of R744 in Renal Anemia Patients on Hemodialysis Hemodialysis Patients | Phase 3 | 2007-02-01 |
| Completed | Clinical Study of R744 to Peritoneal Dialysis Patients Peritoneal Dialysis Patients | Phase 3 | 2007-02-01 |
| Completed | Switch and Maintenance Study of Intravenous Injections of R744 to Hemodialysis Patients (Phase Ⅲ Study) Hemodialysis Patients | Phase 3 | 2007-01-01 |
| Completed | A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Comp Liver Cirrhosis, Chronic Hepatitis C | Phase 3 | 2006-06-01 |
| Completed | PhaseⅢOpen-label Study of MRA for Rheumatoid Arthritis(RA) Rheumatoid Arthritis | Phase 3 | 2006-05-01 |
| Completed | Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer Colorectal Cancer | Phase 1 / Phase 2 | 2006-02-01 |
| Completed | Trial of Pegasys® in Patients With Chronic Hepatitis C Chronic Hepatitis C | Phase 4 | 2005-10-01 |
| Completed | Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA220JP or MRA221JP Rheumatoid Arthritis | Phase 3 | 2005-03-01 |
| Completed | Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA) Polyarticular Juvenile Idiopathic Arthritis | Phase 3 | 2005-02-01 |
| Completed | Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA) Rheumatoid Arthritis | N/A | 2005-02-01 |
| Completed | Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal Impairment Rheumatoid Arthritis | N/A | 2005-01-01 |
| Completed | Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA) Systemic Juvenile Idiopathic Arthritis | Phase 3 | 2004-11-01 |
| Completed | A New Active Vitamin D, ED-71 for Osteoporosis Osteoporosis | Phase 3 | 2004-09-01 |
| Completed | Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA) Systemic Juvenile Idiopathic Arthritis | Phase 3 | 2004-07-01 |
| Completed | Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA213JP Rheumatoid Arthritis | Phase 3 | 2004-06-01 |
| Completed | Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA) Systemic Juvenile Idiopathic Arthritis | Phase 3 | 2004-05-01 |
| Completed | Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA012JP Rheumatoid Arthritis | Phase 3 | 2004-04-01 |
| Completed | Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA) Rheumatoid Arthritis | Phase 3 | 2004-02-01 |
| Completed | A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy Chemotherapy Induced Anemia | Phase 3 | 2004-02-01 |
| Completed | A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy Chemotherapy Induced Anemia | Phase 3 | 2003-12-01 |
| Completed | Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA) Rheumatoid Arthritis | Phase 3 | 2003-03-01 |
| Completed | Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases Breast Cancer, Hypercalcemia of Malignancy, Metastatic Cancer | Phase 1 / Phase 2 | 2002-11-01 |
| Completed | A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Patients With Chronic Hepatitis C Chronic Hepatitis C | Phase 3 | 2002-05-01 |
| Completed | Study of MRA in Patients With Rheumatoid Arthritis (RA) Rheumatoid Arthritis | Phase 2 | 2001-08-01 |